Can Fasting Decrease the Side Effects of Chemotherapy?

Status unconfirmed · Not applicable

Conditions studied: Chemotherapy Effect, Chemotherapeutic Toxicity, Fasting

In brief

This is a prospective randomized crossover trial. Patients will be randomized to the FMD or regular diet during three rounds of chemotherapy. After the third round, patients will cross over to the opposite arm. The primary hypothesis is that there will be fewer cases of Grade 2-4 nausea when patients are in the FMD sequence. The primary objective is to assess differences in toxicities in patients undergoing chemotherapy with a combination of taxol/carboplatin when using a fasting mimicking diet when compared to normal diet before and after treatment.

Key facts

Study ID

NCT04027478

Run by

Sutter Health

People needed

39

Starts

2019-09-01

Expected to finish

2021-02-01

Last updated by the study team

2019-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age and older
• English speaking
• Patients undergoing chemotherapy with Taxol/carboplatin planned for at least 6 cycles
• Willing to comply with diet and tests
• No significant medical problem that would make fasting dangerous (insulin dependent diabetes, history of hypoglycemia)

You may not qualify if…

• Insulin dependent diabetes
• Pregnancy
• History of hypoglycemia, or any other medical condition that the treating physician considers not suitable for fasting

Where it is running

• Sutter Cancer Center — Sacramento, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.